300358 Stock Overview
Engages in medical equipment business in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Truking Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.70 |
| 52 Week High | CN¥12.90 |
| 52 Week Low | CN¥6.66 |
| Beta | 0.54 |
| 11 Month Change | -2.33% |
| 3 Month Change | -15.51% |
| 1 Year Change | -43.79% |
| 33 Year Change | -75.10% |
| 5 Year Change | 0.15% |
| Change since IPO | -40.94% |
Recent News & Updates
Recent updates
Truking Technology (SZSE:300358) Is Due To Pay A Dividend Of CN¥0.10
Jul 15
Truking Technology's (SZSE:300358) Anemic Earnings Might Be Worse Than You Think
May 05Is Truking Technology (SZSE:300358) Using Too Much Debt?
Mar 28Investors Still Aren't Entirely Convinced By Truking Technology Limited's (SZSE:300358) Earnings Despite 27% Price Jump
Mar 06Shareholder Returns
| 300358 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -10.7% | -3.7% | -2.8% |
| 1Y | -43.8% | -15.2% | -18.4% |
Return vs Industry: 300358 underperformed the CN Medical Equipment industry which returned -15.2% over the past year.
Return vs Market: 300358 underperformed the CN Market which returned -18.4% over the past year.
Price Volatility
| 300358 volatility | |
|---|---|
| 300358 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300358 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300358's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 8,826 | Yue Tang | www.truking.cn |
Truking Technology Limited engages in medical equipment business in China and internationally. It is involved in pharmaceutical water business, that includes pharmaceutical water preparation, storage and distribution system, process tank group, public works, etc.; biological engineering, such as biological reaction system, liquid preparation system, separation and purification system, filtration system, disposable reaction system, biological related consumables, etc.; sterile preparations, that includes aseptic dispensing system, powder dispensing system, freeze dryer feeding and discharging system, pre-filling system, isolation system, special dispensing system, etc.; and solid preparations, such as fluidization, granulation, tablet compression, coating, capsules, aluminum-plastic packaging, etc. The company also engages in post-inspection packaging business, that includes light inspection, detection system, post-package system, logistics and warehousing system, etc.; Chinese medicine preparations, such as Chinese medicine extraction, concentration, drying, purification and separation, reaction, crystallization, etc.; AI and informatization systems, etc.; EPCMV services, that includes design and consulting, information construction, verification services, etc.; and cell and gene therapy, such as fully automatic intelligent cell culture equipment and process consumables, etc. Truking Technology Limited was founded in 2000 and is headquartered in Changsha, China.
Truking Technology Limited Fundamentals Summary
| 300358 fundamental statistics | |
|---|---|
| Market cap | CN¥3.96b |
| Earnings (TTM) | CN¥162.83m |
| Revenue (TTM) | CN¥6.69b |
24.3x
P/E Ratio0.6x
P/S RatioIs 300358 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300358 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.69b |
| Cost of Revenue | CN¥4.67b |
| Gross Profit | CN¥2.02b |
| Other Expenses | CN¥1.86b |
| Earnings | CN¥162.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 30.17% |
| Net Profit Margin | 2.43% |
| Debt/Equity Ratio | 33.2% |
How did 300358 perform over the long term?
See historical performance and comparison